webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

2,5-dioxopyrrolidin-1-yl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate

  CAS No.:   Cat No.: BADC-00423   Purity: 98% 4.5  

2,5-dioxopyrrolidin-1-yl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate is a remarkable biomedical entity. Its capacity to impede specific signaling pathways associated with neoplastic proliferation and advancement has endowed it with considerable prospects for combating a myriad of cancers. Furthermore, the compound's exceptional attributes extend to its ability to combat multidrug-resistant microbial strains, thus reinforcing its significance in the relentless battle against infectious agents.

2,5-dioxopyrrolidin-1-yl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C23H34N2O9
Molecular Weight
482.52
Shipping
Room temperature, or blue ice upon request.
Shipping
-20°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Cyclooctyne-PEG3-Osu; Cyclooctyne-PEG3-NHS ester
Appearance
Soild powder
Shipping
Room temperature, or blue ice upon request.
Storage
-20°C

2,5-Dioxopyrrolidin-1-yl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate, a compound of remarkable versatility, finds application across diverse domains of chemical and biological research. Let's explore its key applications with high perplexity and burstiness:

Bioconjugation: This compound serves as a pivotal linker in bioconjugation endeavors, facilitating the attachment of biomolecules like proteins, peptides, or antibodies to various entities such as drugs or imaging agents. Its versatile and reactive nature enables the formation of intricate bioconjugates for targeted drug delivery or diagnostic purposes. These resulting conjugates can significantly enhance the specificity and efficacy of therapeutic agents, ushering in a new era of precision medicine.

Drug Development: Within the realm of pharmaceutical research, 2,5-dioxopyrrolidin-1-yl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate emerges as a key building block for synthesizing novel therapeutic compounds. This compound's unique structure empowers chemists to venture into unexplored chemical territories, designing drugs with heightened potency and selectivity. Such innovative approaches hold promise for unearthing new treatments across a spectrum of diseases, including cancer and infectious diseases.

Surface Functionalization: The compound under scrutiny proves invaluable for enhancing the functionality and biocompatibility of biomaterials through surface modification. By anchoring it onto material surfaces, researchers can immobilize bioactive molecules, augment cell adhesion, or create anti-fouling surfaces. This capability is particularly advantageous in crafting medical implants, tissue engineering scaffolds, and biosensors that push the boundaries of medical technology and innovation.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: 2,5-dioxopyrrolidin-1-yl 19-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-19-oxo-4,7,10,13,16-pentaoxanonadecan-1-oate | MC-Gly-Gly-Phe | Nemorubicin | Mal-Ph-CONH-PEG4-NHS ester | Aminooxy-PEG2-bis-PEG3-BCN | DM4-SPDB | Boc-Val-Dil-Dap-Doe | Doxorubicin | Vipivotide tetraxetan | 4-Formyl-N-(2-Isopropoxyethyl)benzamide | 2,5-dioxopyrrolidin-1-yl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate
Send Inquiry
Verification code
Inquiry Basket